Cancer Immunology Research

Papers
(The H4-Index of Cancer Immunology Research is 36. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-02-01 to 2025-02-01.)
ArticleCitations
Self-Renewing CD8+ T-cell Abundance in Blood Associates with Response to Immunotherapy150
A Sampling of Highlights from the Literature100
Inflammatory Stress Determines the Need for Chemotherapy in Patients with HER2-Positive Esophagogastric Adenocarcinoma Receiving Targeted Therapy and Immunotherapy96
Imaging α-GalCer–Activated iNKT Cells in a Hepatic Metastatic Environment94
KRT17 Promotes T-lymphocyte Infiltration Through the YTHDF2–CXCL10 Axis in Colorectal Cancer88
Inhibition of STAT6 with Antisense Oligonucleotides Enhances the Systemic Antitumor Effects of Radiotherapy and Anti–PD-1 in Metastatic Non–Small Cell Lung Cancer80
Alternative Splicing of the Inhibitory Immune Checkpoint Receptor SLAMF6 Generates a Dominant Positive Form, Boosting T-cell Effector Functions77
Acknowledgment to Reviewers71
Abstract P042: Chemokine dysregulation creates the immunosuppressive tumor microenvironment and promotes human papillomavirus-associated head and neck cancer70
A Sampling of Highlights from the Literature56
CD59-Regulated Ras Compartmentalization Orchestrates Antitumor T-cell Immunity54
All Glioblastoma Are Not Equal: Distinct Spatial Immune Profiles BetweenDe Novoand Recurrent Tumors52
Abstract PO091: Armed Myxoma virus demonstrates efficacy in syngeneic tumor models alone and in combination with immune checkpoint inhibitors51
HIF1α or HIF2α: Enhancing CD8+ T-cell Fitness for Antitumor Immunity51
Discovery of Podofilox as a Potent cGAMP–STING Signaling Enhancer with Antitumor Activity50
VISTA Expression on Cancer-Associated Endothelium Selectively Prevents T-cell Extravasation49
Low Serum Apolipoprotein A1 Levels Impair Antitumor Immunity of CD8+ T Cells via the HIF-1α–Glycolysis Pathway47
Impact of scFv on Functionality and Safety of Third-Generation CD123 CAR T Cells47
CLN-617 Retains IL2 and IL12 in Injected Tumors to Drive Robust and Systemic Immune-Mediated Antitumor Activity47
Intracellular Osteopontin Promotes the Release of TNFα by Mast Cells to Restrain Neuroendocrine Prostate Cancer46
Abstract PO010: The inhibition of IWS1 phosphorylation promotes genomic instability, the cGAS/STING pathway activation and PD-L1 levels, through the U2AF2 alternative RNA splicing and Sororin expressi45
Engineering CD3/CD137 Dual Specificity into a DLL3-Targeted T-Cell Engager Enhances T-Cell Infiltration and Efficacy against Small-Cell Lung Cancer44
Abstract PO019: CD39+PD-1+CD8+ T cells mediate metastatic dormancy in breast cancer43
CD161 Characterizes an Inflamed Subset of Cytotoxic T Lymphocytes Associated with Prolonged Survival in Human Papillomavirus–Driven Oropharyngeal Cancer43
Long-Read Sequencing Reveals Alternative Splicing-Driven, Shared Immunogenic Neoepitopes Regardless of SF3B1 Status in Uveal Melanoma43
The Conventional Dendritic Cell 1 Subset Primes CD8+ T Cells and Traffics Tumor Antigen to Drive Antitumor Immunity in the Brain42
Reciprocal Interactions Between the Gut Microbiome and Mammary Tissue Mast Cells Promote Metastatic Dissemination of HR+ Breast Tumors42
LEF1 Drives a Central Memory Program and Supports Antitumor Activity of Natural Killer T Cells42
A Sampling of Highlights from the Literature40
Martin A. “Mac” Cheever, MD: In Memoriam (1944–2021)38
Accounting for B-cell Behavior and Sampling Bias Predicts Anti–PD-L1 Response in Bladder Cancer38
A Sampling of Highlights from the Literature38
Exercise as an Immune Boost: Mechanism-Driven Support for Lifestyle Interventions38
A Sampling of Highlights from the Literature37
Tumor-Associated High Endothelial Venules: Inroads Enabling Immune Control of Cancer Progression37
Abstract IA16: Discovery of new immunotherapy targets and mechanisms leveraging CRISPR36
A Sampling of Highlights from the Literature36
0.068920135498047